Gelteq (GELS) Stock Price, News & Analysis

Company Overview

Gelteq Inc. is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc. is based in NEW YORK.

Key Stats

• Today's Range: $1.60 to $1.88
• 50-Day Range: $0.87 to $2.95
• 52-Week Range: $0.77 to $5.50
• Volume: 60,982 shs
• Average Volume: 4.00 million shs
• Market Capitalization: $15.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GELS Stock Analysis - Frequently Asked Questions

How have GELS shares performed this year?

Gelteq's stock was trading at $2.32 on January 1st, 2025. Since then, GELS shares have decreased by 31.0% and is now trading at $1.60.
View the best growth stocks for 2025 here.

When did Gelteq IPO?

Gelteq (GELS) raised $5 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 1,300,000 shares at $4.00 per share. The Benchmark Company served as the underwriter for the IPO.

When did Gelteq's lock-up period expire?

Gelteq's lock-up period expired on Monday, April 28th. Gelteq had issued 1,300,000 shares in its public offering on October 29th. The total size of the offering was $5,200,000 based on an initial share price of $4.00. Since the expiration of Gelteq's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

How do I buy shares of Gelteq?

Shares of GELS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 6/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:GELS
• Previous Symbol: NASDAQ:GELS
• CIK: 1920092
• Web: www.gelteq.com
• Phone: 61-3-9087-3990
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $100 thousand
• Price / Sales: 151.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 9,440,000
• Free Float: N/A
• Market Cap: $15.10 million
• Optionable: N/A
• Beta: N/A